AU2003205499A1 - Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides - Google Patents
Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolidesInfo
- Publication number
- AU2003205499A1 AU2003205499A1 AU2003205499A AU2003205499A AU2003205499A1 AU 2003205499 A1 AU2003205499 A1 AU 2003205499A1 AU 2003205499 A AU2003205499 A AU 2003205499A AU 2003205499 A AU2003205499 A AU 2003205499A AU 2003205499 A1 AU2003205499 A1 AU 2003205499A1
- Authority
- AU
- Australia
- Prior art keywords
- inhalable
- macrolides
- acute
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CH2003/000148 WO2004075874A1 (en) | 2003-02-28 | 2003-02-28 | Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003205499A1 true AU2003205499A1 (en) | 2004-09-17 |
Family
ID=32913647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003205499A Abandoned AU2003205499A1 (en) | 2003-02-28 | 2003-02-28 | Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003205499A1 (en) |
WO (1) | WO2004075874A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60330322D1 (en) | 2002-03-26 | 2010-01-14 | Teva Pharma | MEDICINES microparticles |
KR20080105174A (en) * | 2006-04-03 | 2008-12-03 | 테바 파마슈티컬 인더스트리즈 리미티드 | Drug microparticles |
WO2007124382A2 (en) * | 2006-04-19 | 2007-11-01 | Novartis Vaccines And Diagnostics, Inc. | Inhaled imipenem |
US20100093650A1 (en) | 2006-10-11 | 2010-04-15 | Laboratories Smb S.A. | Pharmaceutical Anit-Infective Composition for Inhalation |
WO2009064469A1 (en) * | 2007-11-14 | 2009-05-22 | Nektar Therapeutics | Pulmonary delivery of a macrolide antibiotic |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290707A (en) * | 1994-06-28 | 1996-01-10 | Georgi Stankov | Pharmaceutical uses of Amphotericin B |
ATE219355T1 (en) * | 1997-02-05 | 2002-07-15 | Jago Res Ag | MEDICAL AEROSOL FORMULATIONS |
NZ523693A (en) * | 2000-07-10 | 2004-08-27 | Chiron Corp | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
-
2003
- 2003-02-28 AU AU2003205499A patent/AU2003205499A1/en not_active Abandoned
- 2003-02-28 WO PCT/CH2003/000148 patent/WO2004075874A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004075874A1 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003901008A0 (en) | Composition for the treatment and prevention of bacterial infections | |
AU2003273371A1 (en) | Transnasal method and catheter for lacrimal system | |
EP1812068A4 (en) | Methods of preventing and treating rsv infections and related conditions | |
AU2003238813A1 (en) | Implantable bronchial isolation devices and lung treatment methods | |
AU2002233643A1 (en) | Methods of treating diseases in association with decrease in the expression of AOP-1 gene or AOP-1 and remedies for the diseases | |
EP1594444A3 (en) | Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections | |
AU2003300200A1 (en) | Valve treatment catheter and methods | |
AU2002356868A1 (en) | Methods for the prevention or treatment of bacterial and fungal infections | |
EP1531828A4 (en) | Methods of treating bacterial infections and diseases associated therewith | |
AU2003209851A1 (en) | Method of treatment and/or prophylaxis | |
PT1565201T (en) | Methods of administering dalbavancin for treatment of bacterial infections | |
AU2003270498A1 (en) | Topical veterinary compositions and methods for the treatment and prevention of infection | |
WO2004108840A8 (en) | Nucleotides for prevention and treatment of bacterial and fungal pathologies | |
AU2003205499A1 (en) | Method for treatment and prevention of acute and chronic pseudomonas aeruginosa airway infections with inhalable macrolides | |
AU2006270094A8 (en) | Prevention and treatment of ophthalmic complications of diabetes | |
AU2003272728A1 (en) | Methods and compositions for treatment of neurological disorder | |
IL180459A0 (en) | Treatment of bacterial infections | |
WO2006065301A3 (en) | Compositions for treatment of ear infections | |
AU2003244132A1 (en) | Method of examining allergic disaese and drug for treating the same | |
AU2003291368A1 (en) | Compounds for the treatment of tobacco dependence and withdrawal | |
AU2003238175A1 (en) | Treatment of serious infections and septic shock | |
AU2003290506A1 (en) | Methods and devices for treating severe peripheral bacterial infections | |
AU2002350565A1 (en) | Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections | |
AU2003304316A1 (en) | Compounds and methods for the treatment and prevention of bacterial infection | |
AU2003209241A1 (en) | Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |